Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- CheckyesterdayChange DetectedAdded Rhabdomyosarcoma as a focus term and included Genetic and Rare Diseases Information Center as a Resources link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check8 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study details or visible features.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision updated to v3.4.2. The prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.4%

- Check44 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center operating status has been added, with links to cc.nih.gov and opm.gov. A revision note updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check51 days agoChange DetectedGlossary toggle added to the page. Footer metadata updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and revision 'v3.4.0'; the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision tag updated to v3.3.4, replacing v3.3.3; no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.